Aesthetic Injectables | US | 2018 | Market Analysis
The US market for aesthetic injectables will approach $3 billion by 2026, driven primarily by high patient demand, including from emerging patient groups such as men and younger individuals. New product types, such as fat reduction injectables, and the approval of expanded indications for existing products will also contribute to market growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables in the US across a 10-year period.